2004
DOI: 10.1016/j.jhin.2003.10.014
|View full text |Cite
|
Sign up to set email alerts
|

Three scenarios of clinical claim reimbursement for nosocomial infection: the good, the bad, and the ugly

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 23 publications
0
6
0
Order By: Relevance
“…This finding is particularly important to consider in countries working with a prospective DRG reimbursement system. 3,25 Insurance companies are not necessarily obliged to pay a healthcare facility for treatment of HAIs or for additional infection control measures of patients colonized with nosocomially acquired MDROs, which can put a hospital in a precarious financial situation. To maximize a hospital's cost-effectiveness, it is essential to minimize the number of HAIs and also to minimize the patient's length and expenses of hospital stay.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…This finding is particularly important to consider in countries working with a prospective DRG reimbursement system. 3,25 Insurance companies are not necessarily obliged to pay a healthcare facility for treatment of HAIs or for additional infection control measures of patients colonized with nosocomially acquired MDROs, which can put a hospital in a precarious financial situation. To maximize a hospital's cost-effectiveness, it is essential to minimize the number of HAIs and also to minimize the patient's length and expenses of hospital stay.…”
Section: Discussionmentioning
confidence: 99%
“…However, only transmission of MDROs within the hospital can be prevented by an infection control program. 25 Several limitations of the study should be mentioned. First, our MDRO results cannot be extrapolated one to one to other HAIs such as catheter-related bloodstream infections, pneumonia or surgical-site infections.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Over the past years several adjustments of the DRG system have been made, whereby also hospital acquired infections with multidrug-resistant pathogens should be better reflected. Originally, these costs were not included in DRGs and therefore not covered (Vegni et al, 2004). A positive MDRO-status can be indicated by the secondary diagnosis U80.0!…”
Section: Encoding Of Multiresistant Organism In the German Drg-systemmentioning
confidence: 99%
“…A few studies demonstrate a positive cost-benefit ratio of theses hygiene preventive measures (Farbman et al, 2013). Nevertheless, these additional costs are only partly accounted in hospital financing systems (Vegni et al, 2004). The financial impact of nosocomial infections on reimbursements under prospective Diagnosis Related Group (DRG) conditions is already long controversially debated (DeWitt, 1987).…”
Section: Introductionmentioning
confidence: 99%